FIGURE

Fig. 1

ID

ZDB-FIG-230306-30

Publication

Da'as et al., 2023 - The link between glycemic control measures and eye microvascular complications in a clinical cohort of type 2 diabetes with microRNA-223-3p signature

Other Figures

All Figure Page

Back to All Figure Page

Fig. 1

miR-223-3p is upregulated in individuals with type 2 diabetes and diabetic retinopathy. A A sub-cohort of individuals selected from the Qatar Genome Programme (QGP) participants were stratified into T2D patients and Normal controls based on self-reporting of a physician diagnosis for diabetes or HbA1c levels greater than 6.5%. T2D individuals with diabetic retinopathy (T2D-DR) were identified by examining the retinal images. B Principal component analysis based on biallelic germline variants presents the distribution of case- and control-study samples across the nationwide QGP population with no selection bias in the representative sample. C mi-R223 was identified as the top-upregulated miRNA in our target panel with elevated expression in T2D. D Amongst T2D individuals, miR-223-3p expression was significantly higher in plasma from individuals with DR (T2D-DR) compared to Controls and T2D individuals without DR. Boxplots show the distribution of relative expression for miR-223-3p across all study samples

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ J Transl Med